Form 4 for ISRG Intuitive Surgical
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-26 · accession 0001035267-21-000154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-27 | 2021-08-26 | ISRG | DeSantis Robert | EVP, Chief Product Off | M - OptEx | $736.80 | +397 | 761 | +109% | +$292.5K |
| D | 2021-08-27 | 2021-08-26 | ISRG | DeSantis Robert | EVP, Chief Product Off | S - Sale+OE | $1,048.12 | -397 | 364 | -52% | -$416.1K |
| D | 2021-08-27 | 2021-08-26 | ISRG | DeSantis Robert | EVP, Chief Product Off | M - OptEx | $0.00 | -397 | 2,780 | -12% | $0 |
| D | 2021-08-27 | 2021-08-26 | ISRG | DeSantis Robert | EVP, Chief Product Off | A - Grant | $0.00 | +3,177 | 3,177 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-26 | M | A | 397 | $736.80 | 761 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-26 | S | D | 397 | $1,048.12 | 364 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-26 | M | D | 397 | $0.00 | 2,780 | D | $736.80 · — to 2031-02-26 | 397 Common Stock | (F2) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-26 | A | A | 3,177 | $0.00 | 3,177 | D | $1,042.25 · — to 2031-08-26 | 3,177 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |